CLARINEX SYRUP Rx
Generic Name and Formulations:
Desloratadine 0.5mg/mL; bubble-gum flavor.
Merck & Co., Inc.
Indications for CLARINEX SYRUP:
Seasonal allergic rhinitis (for patients ≥2yrs old). Perennial allergic rhinitis, chronic idiopathic urticaria (for patients ≥6 months old).
Adults and Children:
<6 months: not recommended. 6 months–11 months: 1mg (2mL). 1–5yrs: 1.25mg (2.5mL). 6–11yrs: 2.5mg (5mL). ≥12yrs: 5mg (10mL). All: once daily.
ODT: Phenylketonurics. Pregnancy (Cat.C). Nursing mothers: not recommended.
Pharyngitis, dry mouth or throat, myalgia, fatigue, somnolence, dysmenorrhea, headache, nausea, dizziness. Children: fever, diarrhea, upper respiratory infections, irritability, coughing.
Formerly known under the brand name Clarinex ODT.
Tabs (YES); syrup (NO)
Tabs—100, 500; Syrup—4oz, 16oz; ODT—contact supplier
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Ivacaftor Improves Insulin Secretion in Children With Cystic Fibrosis
- Genetic Testing Recommended for Familial Hypercholesterolemia
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry